Connor Clark & Lunn Investment Management Ltd. Buys 267,574 Shares of Option Care Health, Inc. $OPCH

by · The Markets Daily

Connor Clark & Lunn Investment Management Ltd. lifted its stake in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 116.2% in the second quarter, HoldingsChannel reports. The institutional investor owned 497,939 shares of the company’s stock after buying an additional 267,574 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Option Care Health were worth $16,173,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Fuller & Thaler Asset Management Inc. raised its stake in Option Care Health by 30.8% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company’s stock worth $146,947,000 after acquiring an additional 989,048 shares in the last quarter. Durable Capital Partners LP acquired a new stake in shares of Option Care Health in the 1st quarter valued at $122,905,000. Charles Schwab Investment Management Inc. grew its holdings in shares of Option Care Health by 4.0% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company’s stock worth $91,209,000 after purchasing an additional 99,574 shares during the last quarter. Jennison Associates LLC increased its position in shares of Option Care Health by 145.6% during the 2nd quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock worth $69,450,000 after purchasing an additional 1,267,660 shares in the last quarter. Finally, Nuveen LLC acquired a new stake in shares of Option Care Health during the 1st quarter worth about $70,965,000. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Price Performance

Shares of OPCH stock opened at $28.18 on Tuesday. The firm has a market cap of $4.47 billion, a price-to-earnings ratio of 22.54, a PEG ratio of 1.74 and a beta of 0.88. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The stock has a 50-day moving average price of $27.78 and a 200 day moving average price of $29.67.

Option Care Health (NASDAQ:OPCH – Get Free Report) last issued its earnings results on Thursday, October 30th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.41 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.41 EPS. Option Care Health has set its FY 2025 guidance at 1.680-1.720 EPS. Research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have commented on OPCH. JMP Securities set a $36.00 price target on shares of Option Care Health in a research report on Friday, October 31st. TD Cowen decreased their price target on Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a research report on Monday, November 3rd. Barrington Research reiterated an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research report on Friday, October 31st. Citigroup restated an “outperform” rating on shares of Option Care Health in a report on Friday, October 31st. Finally, Morgan Stanley assumed coverage on Option Care Health in a research note on Friday, October 17th. They issued an “overweight” rating and a $35.00 target price for the company. Nine analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $35.67.

Read Our Latest Research Report on Option Care Health

Insiders Place Their Bets

In related news, Director Norman L. Wright acquired 3,411 shares of the firm’s stock in a transaction that occurred on Tuesday, September 9th. The stock was acquired at an average cost of $29.31 per share, with a total value of $99,976.41. Following the completion of the purchase, the director directly owned 15,501 shares in the company, valued at approximately $454,334.31. This trade represents a 28.21% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy P. Sullivan bought 20,000 shares of the business’s stock in a transaction on Thursday, August 21st. The stock was bought at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the purchase, the director directly owned 49,229 shares of the company’s stock, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders acquired 97,411 shares of company stock valued at $2,614,816. Company insiders own 0.64% of the company’s stock.

About Option Care Health

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Further Reading

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).